Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vector

Gene Therapy

Volumn 4, Issue 5, 1997, Pages 393-400

  Wang, Q ^a   Greenburg, G ^a   Bunch, D ^a   Farson, D ^a   Finer, M H ^a  

^a CELL GENESYS INC   (United States)

Author keywords

Cytopathic effects; Immune response; Transgene expression; E1 E4 adenovirus vector

Indexed keywords

ADENOVIRUS; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; EXPRESSION VECTOR; GENE DELETION; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN CELL; LIVER; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; VIRUS GENE; VIRUS IMMUNITY;

ADENOVIRIDAE; ANIMALIA;

EID: 0031008929     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300404     Document Type: Article

References (32)

1. Kay MA et al. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 1994; 91: 2353-2357.
2. Setoguchi Y, Jaffe HA, Chu C-S, Crystal RG. Intraperitoneal in vivo gene therapy to deliver α-antitrypsin to the systemic circulation. Am J Respir Cell Mol Biol 1994; 10: 369-377.
3. Kozarsky KF et al. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 1994; 269: 13695-13702.
4. Vincent MC et al. Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum Gene Ther 1995; 6: 1019-1028.
5. Valentine RC, Pereira HG. Antigens and structure of the adenovirus. J Mol Biol 1965; 13: 13-20.
6. Dai Y et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995; 92: 1401-1405.
7. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994; 91: 6196-6200.
8. Yang Y et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
9. Yang Y, Ertl HCJ, Wilson JM. MHC class 1-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994; 1: 433-442.
10. Fang B et al. Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs. Gene Therapy 1996; 3: 217-222.
11. Lochmuller HJ et al. Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum Gene Ther 1994; 5: 1485-1491.
12. Wang Q, Jia X-C, Finer MH. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Gene Therapy 1995; 2: 775-783.
13. Halbert DN, Cutt JR, Shenk T. Adenovirus early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J Virol 1985; 56: 250-257.
14. Weinberg DH, Ketner G. Adenoviral early region 4 is required for efficient viral DNA replication and for late gene expression. J Virol 1986; 57: 833-838.
15. Wang Q, Dai F, Finer MH. Late gene expression and genome stability of ΔE1/ΔE4 Ad vector: a 293-ORF6 packaging cell line to prevent 'healing' of E4 deletion. (Submitted).
16. Bridge E, Ketner G. Redundant control of adenovirus late gene expression by early region 4. J Virol 1989; 63: 631-638.
17. Weinberg DH, Ketner G. A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2. Proc Natl Acad Sci USA 1983; 80: 5383-5386.
18. Gooding LR, Wold WSM. Molecular mechanisms by which adenoviruses counteract antiviral immune defenses. Crit Rev Immunol 1990; 10: 53-71.
19. Reichel R, Kovesdi I, Nevins M Jr. Developmental control of a promoter-specific factor that is also regulated by the E1A gene product. Cell 1987; 48: 501-506.
20. Bridge EB et al. Adenovirus early region 4 and viral DNA synthesis. Virology 1993; 193: 794-801.
21. Sandler AB, Ketner G. Adenovirus early region 4 is essential for normal stability of late nuclear RNAs. J Virol 1989; 63: 624-630.
22. Chen PH, Ornelles DA, Shenk TJ. The adenovirus L3 23-kilodalton proteinase cleaves the amino-terminal head domain from cytokeratin 18 and disrupts the cytokeratin network of HeLa cells. J Virol 1993; 67: 3507-3514.
23. Wang Q, Taylor MW. Correction of deletion mutant using adenovirus vector. Mol Cell Biol 1993; 13: 918-927.
24. Ayurni F, Keiko S, Yumi D, Izumu S, Ichizo K. Gene targeting with a replication-defective adenovirus vector. J Virol 1995; 69: 6180-6190.
25. Ketner G, Bridge E, Virtanen A, Hemstrom C, Pettersson U. Complementation of adenovirus E4 mutants by transient expression of E4 cDNA and deletion plasmids. Nucleic Acids Res 1989; 17: 3037-3048.
26. Thimmappaya B, Weinberger C, Schneider RJ, Shenk T. Adenovirus VA I RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 1982; 31: 543-551.
27. Juillard V et al. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur J Immnol 1995; 25: 3467-3473.
28. Yang Y et al. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Therapy 1996; 3: 137-144.
29. Graham FL, Prevec L. Adenovirus-based expression vectors and recombinant vaccines. In: Ellis RW (ed). Vaccines: New Approaches to Immunological Problems. Butterworth-Heinemann: Boston, MA, 1992, pp 363-390.
30. Cheng T-C, Wallace MC, Merlie JP, Olson EN. Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science 1993; 261: 215-218.
31. MacGregor GR, Mogg AE, Burke JF, Caskey CT. Histochemical staining of clonal mammalian cell lines expressing E. coli β-galactosidase indicate heterogeneous expression of the bacterial gene. Somatic Cell Mol Genet 1987; 13: 253-264.
32. Freshney RI (ed). Disaggregation of the tissue and primary culture. In: Culture of Animal Cells - A Manual of Basic Techniques, 2nd edn. Wiley-Liss: New York, NY, 1988, pp 107-126.